We are live on !
Find out more
TRV GP IV Portfolio holdings
AUM
$254M
Turnover
0%
1-Year Est. Return
426.76%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+426.76%
3 Year Est. Return
+1,102.13%
5 Year Est. Return
+979.15%
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$13.2M
(-5%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
3
years
Top 10 Avg Time Held
3
years
Top 20 Avg Time Held
3
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Maze Therapeutics
MAZE
$1.75B
| $134M | 52.63% |
4,473,958
| – | – |
2025 Q1
5 quarters
|
|
2
Tango Therapeutics
TNGX
$3.83B
| $120M | 47.37% |
6,374,574
| – | – |
2021 Q3
19 quarters
|
|
Similar funds
ECM
TRV GP IV's Q2 2026 Portfolio in Review
As of Q2 2026, TRV GP IV held 2 positions worth $254M, down 5% from $267M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 0%. TRV GP IV opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP IV's ten largest holdings make up 100% of its $254M portfolio in Q2 2026.
- TRV GP IV opened 0 new positions and closed 0 in Q2 2026.
- TRV GP IV's portfolio value fell 5% quarter-over-quarter to $254M.
Based on TRV GP IV's 13F filing for Q2 2026, filed 10 Aug 2026.